Skip to main content
INDUCTION HEALTHCARE GROUP PLC logo

INDUCTION HEALTHCARE GROUP PLC — Investor Relations & Filings

Ticker · INHC ISIN · GB00BJ0M3545 LEI · 213800RY96GCZQW5TP19 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 140 across all filing types
Latest filing 2024-07-29 Regulatory Filings
Country GB United Kingdom
Listing IL INHC

About INDUCTION HEALTHCARE GROUP PLC

https://inductionhealthcare.com/

Induction Healthcare Group PLC is a healthcare technology company specializing in digital solutions that streamline care delivery and enhance patient engagement. The company's core offering is a Software-as-a-Service (SaaS) patient portal platform, which facilitates flexible appointment management, digital form completion, video consultations, and secure messaging. Designed for healthcare providers such as NHS Trusts and private organizations, the platform integrates with existing hospital IT systems to improve operational efficiency, reduce patient non-attendance rates, and empower patients with greater control over their healthcare journey. Key capabilities include digital registration, paperless workflows, and data analytics to optimize care pathways.

Recent filings

Filing Released Lang Actions
Block Listing Six Monthly Return
Regulatory Filings Classification · 1% confidence The document is titled 'Block Listing Six Monthly Return' and explicitly references 'AIM Rule 29 and Schedule 6 of the AIM Rules for Companies'. It provides a structured update on the status of shares under a specific share option plan over a defined period (28/01/2024 to 27/07/2024). This type of periodic return concerning the admission of shares to a listing, often required by exchange rules (like AIM), is a specific regulatory disclosure. While it contains structured data, it is not a comprehensive financial report (10-K, IR) or a general earnings announcement (ER). It is a specific regulatory filing related to share capital management. Given the options, 'Regulatory Filings' (RNS) is the most appropriate general category for specific, non-financial, periodic compliance updates that don't fit other specific codes like DIRS or DIV, although it is highly specific. However, since the content is a formal return required by the exchange rules regarding the block listing, and it is distributed via RNS, it fits best under the general regulatory disclosure category, RNS, as it is not a standard financial report or a specific transaction report like POS or SHA.
2024-07-29 English
Grant of Options
Director's Dealing Classification · 1% confidence The document is an official announcement from Induction Healthcare Group PLC, identified by the RNS Number and the presence of the RNS header/footer, indicating it is a regulatory disclosure to the London Stock Exchange. The content explicitly details the 'Grant of Options' to senior management (CEO and CFO) under a share option plan. This type of filing, which reports personal share transactions or grants to Persons Discharging Managerial Responsibilities (PDMRs), falls under the category of Director's Dealing (DIRS) or potentially a general Regulatory Filing (RNS). Since there is a specific category for 'Director's Dealing' (DIRS) which covers reports of personal share transactions by executives, this is the most precise classification. Although it mentions the FY24 results announcement, the core subject is the option grant, not the results themselves.
2024-07-17 English
Final Results
Earnings Release Classification · 1% confidence The document explicitly states it announces the "FY24 Audited Final Results" for the year ended 31 March 2024. It contains detailed financial highlights (Revenues, Gross margin, Adjusted EBITDA, Loss for the year, Net cash) and operational highlights, followed by a Chair's Statement and CEO Statement discussing the full year's performance. This content structure is characteristic of a comprehensive annual financial report summary. Crucially, the document concludes with a section titled "Annual Report and Accounts and Notice of AGM" which states that the full Annual Report and Accounts will be available later that day on the company website. Because this document provides the detailed results summary and commentary, but points to the *full* Annual Report and Accounts being published separately (or later the same day), it functions as the primary announcement of the results, which aligns best with the Earnings Release (ER) or, given the depth and the mention of 'Audited Final Results', it is the core content of the Annual Report itself, but presented via an RNS mechanism. However, the presence of the full financial review, Chair's statement, and CEO statement, combined with the explicit mention of 'Audited Final Results' and the fiscal year end, strongly suggests this is the substance of the Annual Report (10-K equivalent for AIM listed companies, though 10-K is US specific). Since the document contains the full narrative and financial summary, it is more than just an 'Earnings Release' (ER) which is usually just highlights. Given the context of a UK listed company (AIM: INHC) announcing 'Audited Final Results' and then mentioning the 'Annual Report and Accounts' will be posted later, this document serves as the primary disclosure of the annual performance. If the document were short and only pointed to the report, it would be RPA. Since it contains the substance of the results, it is classified as the Annual Report (AR) or the closest equivalent for comprehensive annual results disclosure, which is 'AR' (Audit Report / Information) or '10-K' (Annual Report). Given the comprehensive nature covering the full fiscal year and audited figures, '10-K' is the closest conceptual match for a full annual report, although 'AR' (Audit Report / Information) is also plausible. Since it contains the full narrative and audited results summary, I will classify it as the Annual Report (10-K) as it covers the full year's activity and performance, even if it's an RNS announcement format. Re-evaluating the definitions: 10-K is 'Official yearly report covering company activity and full financial performance.' AR is 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports).' This document contains the full results and management commentary, making it the substance of the Annual Report. I will use 10-K as the best fit for the comprehensive annual results disclosure. FY 2024
2024-07-04 English
AMENDMENT: DIVESTMENT OF HORIZON
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number' and is clearly distributed via RNS, which is identified as the news service of the London Stock Exchange and a Primary Information Provider. The content announces a specific corporate action: the 'Divestment of Horizon Strategic Partners Limited' and includes an amendment to a previous announcement. This type of immediate, material corporate news release, especially one originating from the RNS system, falls under the general category of regulatory announcements. Since it is not a full annual report (10-K), a quarterly report (IR), an earnings release (ER), or a specific transaction like a share buyback (POS) or director dealing (DIRS), the most appropriate general classification for a material, non-standard regulatory update distributed via RNS is 'Regulatory Filings' (RNS). The document length (4880 chars) is substantial enough to be the primary announcement, not just a notice of publication (RPA).
2024-07-01 English
DIVESTMENT OF HORIZON STRATEGIC PARTNERS LIMITED
M&A Activity Classification · 1% confidence The document is a formal announcement released via RNS (RNS Number: 4750U) on July 1, 2024, detailing the 'DIVESTMENT OF HORIZON STRATEGIC PARTNERS LIMITED'. This is a specific corporate action announcement regarding the sale of a subsidiary for cash and a convertible loan. It is not a full annual report (10-K), an earnings release (ER), or a quarterly report (IR). Since it details a significant corporate transaction (divestment/sale of a business unit), it falls under the category of a major corporate event announcement. While it could potentially be classified as 'Regulatory Filings' (RNS) as a general catch-all, the content specifically relates to a transaction that impacts the company's structure and assets. However, none of the specific codes (like TAR for M&A) perfectly fit a divestment of a non-core asset unless it was a merger or takeover bid. Given the context of RNS distribution and the nature of the announcement (a specific corporate event disclosure), the most appropriate general classification for a significant, non-standard disclosure that isn't covered by the other specific codes (like DIV, CAP, SHA) is the general regulatory announcement category, RNS. The document explicitly states it is provided by RNS and is an official regulatory notification.
2024-07-01 English
Publication of Full Year Financial Results Delayed
Report Publication Announcement Classification · 1% confidence The document is a short announcement (3105 characters) released via RNS (London Stock Exchange news service). The core content is that the 'audited final results for the year ended 31 March 2024' will be delayed from the planned date of July 1st, and the new publication date will be no later than July 8th, 2024. This is not the full financial report (10-K or IR), nor is it the initial earnings release (ER) which typically contains the results. Instead, it is an announcement *about* the publication timing of a future report. According to Rule 2, when a document is short and announces the publication of another report, it should be classified as a Report Publication Announcement (RPA). The presence of the RNS header and footer further supports this being a regulatory announcement regarding a report.
2024-06-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.